Business · 19/05/2004Updated: 10/17/2026 · 1 min read
FDA Extends Comment Period for Piroctone Olamine Review
Summary
The FDA is extending the comment period for its review of piroctone olamine, a potential ingredient for treating dandruff, until August 16, 2004, to allow more time for public input and data submission.